[New plasma derivatives].
D000751:Anemia, Neonatal / Q000517:prevention & control; D001779:Blood Coagulation Factors; D001728:Dicumarol / Q000037:antagonists & inhibitors; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005169:Factor VIII; D005260:Female; D005340:Fibrinogen; D006467:Hemophilia A / Q000188:drug therapy; D002836:Hemophilia B / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy; D006506:Hepatitis A / Q000517:prevention & control; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D008107:Liver Diseases / Q000188:drug therapy; D010949:Plasma; D011247:Pregnancy; D013742:Tetanus / Q000517:prevention & control; D014020:Tissue Extracts / Q000302:isolation & purification
D001779:Blood Coagulation Factors; D007136:Immunoglobulins; D014020:Tissue Extracts; D001728:Dicumarol; D005169:Factor VIII; D005340:Fibrinogen
Nouveaux dérivés du plasma.